CD4 and myeloid sarcoma: Here, we explore the use of a novel dendritic cell (DC)-targeted chimeric antigen receptor (CAR)-T cell as well as CAR-Treg approach for suppressing pathogenic CD4+ T cell immunity and reinforcing the Treg compartment in experimental autoimmune encephalomyelitis (EAE), an animal model of MS.